Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04569149 · ClinicalTrials.gov registry record
Primordial Dwarfism Registry
A clinical trial of MOPDII and Meier-Gorlin Syndrome, sponsored by Nemours Children's Clinic.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT04569149: Recruiting study of MOPDII and Meier-Gorlin Syndrome, sponsored by Nemours Children's Clinic.
NCT04569149 is a study of MOPDII and Meier-Gorlin Syndrome that is actively recruiting participants, run by Nemours Children's Clinic. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04569149, a study of MOPDII and Meier-Gorlin Syndrome, is actively recruiting participants, sponsored by Nemours Children's Clinic.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this registry is to collect information on individuals with forms of microcephalic primordial dwarfism as well as related conditions. The study team hopes to learn more about these conditions and improve the care of people with them by establishing this registry.
Primary Outcome
Data will be collected at enrollment, and over time, to allow for analysis of associated concerns throughout the lifespan
Conditions Studied
Study Locations (1)
Delaware
- Nemours - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2008-03-11 |
| Est. Completion | 2030-01-01 |
What NCT04569149 shows while recruiting
NCT04569149 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 7 conditions, with MOPDII appearing as the primary indexed condition, and to 0 interventions.
NCT04569149 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT04569149 about?
NCT04569149 is a clinical study titled "Primordial Dwarfism Registry". The goal of this registry is to collect information on individuals with forms of microcephalic primordial dwarfism as well as related conditions. The study team hopes to learn more about these conditions and improve the care of people with them by establishing this registry.
What is the current status of trial NCT04569149?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2008-03-11. Estimated completion is 2030-01-01.
What conditions does trial NCT04569149 study?
This clinical trial studies the following conditions: MOPDII, Meier-Gorlin Syndrome, Saul-Wilson Syndrome, Microcephalic Primordial Dwarfism, IMAGe Syndrome.
Who is sponsoring clinical trial NCT04569149?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04569149 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI